FDA Approves Ketamine Product, KETARx, for Surgical Pain Management
2025-08-18
Drugmaker aims to pursue other applications in mental health, neurological, and pain disordersContinue Reading
Taking One Step Can Boost Your Odds Of Kicking A Drug Habit
2025-08-15
FRIDAY, Aug. 15, 2025 (HealthDay News) — Folks fighting an addiction can boost their chances of success if they also drop the smokes, a new study says. Addicts who quit smoking have up to 42% better odds of recovery, researchers reported Aug. 13 in JAMA Psychiatry. These results indicate thatContinue Reading
New Means Found For Treating Blood Staph Infections
2025-08-14
THURSDAY, Aug. 14, 2025 (HealthDay News) — A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant bacteria, according to new clinical trial results. Two intravenous doses of the antibiotic dalbavancin delivered seven days apart worked just as well as daily IVContinue Reading
FDA Approves Ajovy for Migraine Prevention in Children and Teens
2025-08-11
Approval is for children and adolescents aged 6 to 17 years weighing ≥45 kgContinue Reading
Nearly 9 in 10 ER Patients Aren’t Fully Vaccinated
2025-08-11
MONDAY, Aug. 11, 2025 (HealthDay News) — Nearly 9 out of 10 adults who land in an ER haven’t been fully vaccinated, a new study says. People who came to an emergency department for treatment of minor injuries or illnesses were often unaware of the vaccines available to them, researchersContinue Reading
AMA, AAP, IDSA Among Organizations Disinvited From CDC Vaccine Workgroups
2025-08-08
Move follows RFK Jr.’s abrupt dismissal of the entire ACIP in June, alleging it was too aligned with manufacturersContinue Reading
RFK Jr. Cancels $500M in mRNA Vaccine Research Projects
2025-08-07
THURSDAY, Aug. 7, 2025 (HealthDay News) — U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development, the agency announced Tuesday. The funding had been awarded to 22 research projects managed byContinue Reading
FDA Approves Vizz Eye Drops to Improve Near Vision in Adults
2025-08-06
Trials show once-daily drops are safe and effectiveContinue Reading
FDA Requiring Stronger Safety Labels for Opioid Medications
2025-08-04
Updated opioid safety labeling is based on new data from two large postmarketing observational studiesContinue Reading
Bans on Flavored Vapes Have Pros And Cons, Study Finds
2025-07-31
THURSDAY, July 31, 2025 (HealthDay News) — State bans on enticing flavors of e-cigarettes bring real benefits in terms of lowering vaping among adults of any age, new research finds. But it points to a downside, too: A slowdown in statewide declines of cigarette smoking after flavored vapes were banned. Continue Reading